| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | cell morphogenesis | RELN ARHGAP15 NCKAP1 KALRN FAT3 TRPC5 SRC NFASC GRIN1 SHTN1 GRHL2 KIF3A CCDC88C IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN CDH3 PHIP EPHA5 BRWD1 | 1.87e-08 | 1194 | 120 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection development | RELN SETX NCKAP1 KALRN UBE4B GPR37 FAT3 TRPC5 ZMYND8 NFASC GRIN1 SHTN1 NCS1 KIF3A IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN EPHA5 | 1.21e-06 | 1285 | 120 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of dendritic spine maintenance | 3.13e-06 | 18 | 120 | 4 | GO:1902950 | |
| GeneOntologyBiologicalProcess | neuron development | MYT1L RELN SETX NCKAP1 KALRN UBE4B GPR37 FAT3 TRPC5 ZMYND8 NFASC GRIN1 SHTN1 NCS1 KIF3A IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN EPHA5 | 3.15e-06 | 1463 | 120 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell junction organization | RELN KALRN SRC ZMYND8 WHAMM NFASC GRIN1 GRIN2B GRHL2 PTPRT DST SHANK2 ELAVL2 MACF1 POTEJ FYN CDH3 PDZRN3 EPHA5 | 3.43e-06 | 974 | 120 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | dendritic spine organization | 4.93e-06 | 115 | 120 | 7 | GO:0097061 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | RELN NCKAP1 KALRN TRPC5 SRC NFASC GRIN1 SHTN1 IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN EPHA5 | 5.28e-06 | 819 | 120 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | RELN NCKAP1 KALRN TRPC5 SRC NFASC GRIN1 SHTN1 IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN EPHA5 | 5.90e-06 | 826 | 120 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | neuron projection organization | 9.50e-06 | 127 | 120 | 7 | GO:0106027 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | RELN NCKAP1 KALRN TRPC5 NFASC GRIN1 SHTN1 IGF2BP1 TAOK3 DST VPS13A MACF1 POTEJ ROBO3 FYN EPHA5 | 1.67e-05 | 802 | 120 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | dendritic spine maintenance | 2.66e-05 | 30 | 120 | 4 | GO:0097062 | |
| GeneOntologyBiologicalProcess | dendrite development | 2.67e-05 | 335 | 120 | 10 | GO:0016358 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | RELN SETX NCKAP1 KALRN TRPC5 SRC ZMYND8 GRIN1 SHTN1 MACF1 ROBO3 FYN | 3.16e-05 | 494 | 120 | 12 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | RELN SETX NCKAP1 KALRN FAT3 TRPC5 SRC ZMYND8 GRIN1 GRIN2B SHTN1 NCS1 MACF1 DAAM2 ROBO3 FYN | 3.20e-05 | 846 | 120 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | RELN SETX NCKAP1 KALRN TRPC5 SRC ZMYND8 WHAMM GBP3 GRIN1 SHTN1 KIF3A EHD2 MACF1 VPS28 PIP4K2C ROBO3 FYN ANAPC7 CNOT1 PHIP | 3.78e-05 | 1366 | 120 | 21 | GO:0051130 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | RELN SETX NCKAP1 KALRN FAT3 TRPC5 SRC ZMYND8 GRIN1 GRIN2B SHTN1 NCS1 MACF1 DAAM2 ROBO3 FYN | 4.06e-05 | 863 | 120 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 6.93e-05 | 302 | 120 | 9 | GO:0022604 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 9.11e-05 | 313 | 120 | 9 | GO:0099173 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.06e-04 | 185 | 120 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 1.13e-04 | 43 | 120 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | SETX KALRN SRC PTPRT BLK FRK SGPL1 VPS13A PIP4K2C VEGFD FYN CDH3 PHIP EPHA5 | 1.14e-04 | 747 | 120 | 14 | GO:0007169 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | RELN KALRN FAT3 TRPC5 NFASC GRIN1 SHTN1 IGF2BP1 DST MACF1 POTEJ ROBO3 FYN EPHA5 | 1.15e-04 | 748 | 120 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | RELN KALRN TRPC5 NFASC GRIN1 SHTN1 DST MACF1 POTEJ ROBO3 FYN EPHA5 | 1.16e-04 | 566 | 120 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.61e-04 | 198 | 120 | 7 | GO:0048813 | |
| GeneOntologyBiologicalProcess | synapse organization | RELN KALRN ZMYND8 NFASC GRIN1 GRIN2B PTPRT SHANK2 ELAVL2 POTEJ FYN PDZRN3 EPHA5 | 1.79e-04 | 685 | 120 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | central nervous system development | SOX10 RELN NCKAP1 SPTBN1 SRC NFASC GRIN1 GRIN2B GRHL2 KIF3A IGF2BP1 VPS13A DAAM2 NHEJ1 FYN ANAPC7 TP53BP2 EPHA5 | 1.91e-04 | 1197 | 120 | 18 | GO:0007417 |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 2.75e-04 | 54 | 120 | 4 | GO:0048013 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | RELN ARHGAP15 NCKAP1 RASGRF2 KALRN SRC GRIN2B SHTN1 ITPKB CCDC88C ARHGAP25 | 3.07e-04 | 538 | 120 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | cellular component maintenance | 3.11e-04 | 101 | 120 | 5 | GO:0043954 | |
| GeneOntologyBiologicalProcess | axon development | RELN KALRN TRPC5 NFASC GRIN1 SHTN1 DST MACF1 POTEJ ROBO3 FYN EPHA5 | 3.68e-04 | 642 | 120 | 12 | GO:0061564 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.87e-04 | 59 | 120 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 4.40e-04 | 387 | 120 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | cell junction assembly | RELN SRC WHAMM NFASC GRIN1 GRHL2 DST SHANK2 ELAVL2 MACF1 CDH3 | 4.92e-04 | 569 | 120 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine maintenance | 4.96e-04 | 6 | 120 | 2 | GO:1902951 | |
| GeneOntologyBiologicalProcess | NMDA selective glutamate receptor signaling pathway | 4.96e-04 | 6 | 120 | 2 | GO:0098989 | |
| GeneOntologyBiologicalProcess | response to glycine | 4.96e-04 | 6 | 120 | 2 | GO:1905429 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 5.07e-04 | 27 | 120 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 5.10e-04 | 395 | 120 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 5.61e-04 | 65 | 120 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 5.65e-04 | 115 | 120 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine maintenance | 6.92e-04 | 7 | 120 | 2 | GO:1902952 | |
| GeneOntologyBiologicalProcess | cellular response to progesterone stimulus | 6.92e-04 | 7 | 120 | 2 | GO:0071393 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 7.45e-04 | 333 | 120 | 8 | GO:0051056 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 8.36e-04 | 339 | 120 | 8 | GO:0048193 | |
| GeneOntologyCellularComponent | axon | RELN SETX SPTBN1 TRPC5 SRC NFASC GRIN1 GRIN2B SHTN1 ARMCX3 NCS1 KIF3A IGF2BP1 DST SHANK2 SYNJ2 SCN10A POTEJ ROBO3 EPHA5 | 2.18e-07 | 891 | 122 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | asymmetric synapse | KALRN SPTBN1 EIF3E GRIN1 GRIN2B PTPRT NCS1 DST SHANK2 ELAVL2 MACF1 FYN | 2.33e-05 | 477 | 122 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | KALRN SPTBN1 SRC EIF3E GRIN1 GRIN2B PTPRT NCS1 DST SHANK2 MACF1 FYN | 3.90e-05 | 503 | 122 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | neuron to neuron synapse | KALRN SPTBN1 EIF3E GRIN1 GRIN2B PTPRT NCS1 DST SHANK2 ELAVL2 MACF1 FYN | 5.68e-05 | 523 | 122 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | postsynaptic density | KALRN SPTBN1 EIF3E GRIN1 GRIN2B PTPRT NCS1 DST SHANK2 MACF1 FYN | 6.83e-05 | 451 | 122 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | postsynapse | NCKAP1 KALRN SPTBN1 SRC ZMYND8 EIF3E GRIN1 GRIN2B PTPRT NCS1 KIF3A IGF2BP1 DST SHANK2 ELAVL1 MACF1 FYN | 8.79e-05 | 1018 | 122 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | somatodendritic compartment | RELN KALRN GPR37 FAT3 TRPC5 SRC ZMYND8 NFASC GRIN1 GRIN2B SHTN1 NCS1 KIF3A IGF2BP1 SHANK2 VPS13A ASTN2 FYN EPHA5 | 9.00e-05 | 1228 | 122 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | distal axon | 2.38e-04 | 435 | 122 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT8 NCKAP1 SRC WHAMM KEAP1 SHTN1 KIF3A KRT76 DST SHANK2 SYNJ2 MACF1 POTEJ FYN KRT37 | 2.38e-04 | 899 | 122 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | glutamatergic synapse | RASGRF2 KALRN SPTBN1 SRC GRIN1 GRIN2B PTPRT NCS1 KIF3A SHANK2 SCN10A ELAVL2 ELAVL1 FYN | 2.98e-04 | 817 | 122 | 14 | GO:0098978 |
| GeneOntologyCellularComponent | neuronal cell body | RELN KALRN TRPC5 SRC GRIN1 GRIN2B SHTN1 KIF3A IGF2BP1 SHANK2 VPS13A ASTN2 FYN EPHA5 | 3.71e-04 | 835 | 122 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | dendrite | RELN GPR37 FAT3 TRPC5 SRC ZMYND8 NFASC GRIN1 GRIN2B NCS1 IGF2BP1 SHANK2 FYN EPHA5 | 4.86e-04 | 858 | 122 | 14 | GO:0030425 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT8 NCKAP1 SPTBN1 SRC WHAMM GRIN2B KEAP1 SHTN1 KIF3A KRT76 DST SHANK2 SYNJ2 MACF1 POTEJ FYN KRT37 | 4.95e-04 | 1179 | 122 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | dendritic tree | RELN GPR37 FAT3 TRPC5 SRC ZMYND8 NFASC GRIN1 GRIN2B NCS1 IGF2BP1 SHANK2 FYN EPHA5 | 4.97e-04 | 860 | 122 | 14 | GO:0097447 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT8 NCKAP1 SPTBN1 SRC WHAMM GRIN2B KEAP1 SHTN1 KIF3A KRT76 DST SHANK2 SYNJ2 MACF1 POTEJ FYN KRT37 | 5.34e-04 | 1187 | 122 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | growth cone | 5.96e-04 | 245 | 122 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | dendritic branch | 6.96e-04 | 7 | 122 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.20e-04 | 253 | 122 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | cell body | RELN KALRN TRPC5 SRC GRIN1 GRIN2B SHTN1 KIF3A IGF2BP1 SHANK2 VPS13A ASTN2 FYN EPHA5 | 1.05e-03 | 929 | 122 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.18e-03 | 9 | 122 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.47e-03 | 210 | 122 | 6 | GO:0031256 | |
| GeneOntologyCellularComponent | actin filament | 1.67e-03 | 146 | 122 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 2.04e-03 | 576 | 122 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | intermediate filament | 2.18e-03 | 227 | 122 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | cell leading edge | 2.68e-03 | 500 | 122 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | KALRN SRC GBP3 SHTN1 NCS1 EHD2 IGF2BP1 DST SYNJ2 CTLA4 FYN TP53BP2 EPHA5 | 3.18e-03 | 934 | 122 | 13 | GO:0048471 |
| MousePheno | impaired coordination | MYT1L RELN SETX KALRN UBE4B GPR37 SRC GRIN1 GRIN2B DST SHANK2 VPS13A ELAVL3 | 2.25e-05 | 478 | 96 | 13 | MP:0001405 |
| MousePheno | abnormal motor coordination/balance | MYT1L RELN SETX KALRN UBE4B GPR37 SRC GRIN1 GRIN2B TAOK3 DST SHANK2 EGR3 VPS13A SCN10A ELAVL3 ROBO3 ANAPC7 | 2.34e-05 | 873 | 96 | 18 | MP:0001516 |
| MousePheno | postnatal lethality | SOX10 RELN SRC NFASC GRIN1 GRIN2B KEAP1 PPP1R13L SHTN1 RLF IGF2BP1 DST SHANK2 PROKR2 EGR3 SGPL1 ELAVL2 CCDC65 PHIP TP53BP2 | 3.82e-05 | 1084 | 96 | 20 | MP:0002082 |
| MousePheno | absence of NMDA-mediated synaptic currents | 4.67e-05 | 2 | 96 | 2 | MP:0001901 | |
| Domain | SH3 | KALRN SRC PPP1R13L UBASH3A SH3BP4 BLK FRK DST SHANK2 MACF1 FYN TP53BP2 | 1.49e-08 | 216 | 120 | 12 | PS50002 |
| Domain | SH3_domain | KALRN SRC PPP1R13L UBASH3A SH3BP4 BLK FRK DST SHANK2 MACF1 FYN TP53BP2 | 1.82e-08 | 220 | 120 | 12 | IPR001452 |
| Domain | ELAD_HUD_SF | 1.03e-06 | 4 | 120 | 3 | IPR006548 | |
| Domain | SH3_1 | 1.13e-06 | 164 | 120 | 9 | PF00018 | |
| Domain | SH3 | KALRN SRC PPP1R13L UBASH3A SH3BP4 BLK FRK SHANK2 FYN TP53BP2 | 1.33e-06 | 216 | 120 | 10 | SM00326 |
| Domain | Spectrin | 1.31e-05 | 23 | 120 | 4 | PF00435 | |
| Domain | Hud_Sxl_RNA | 3.00e-05 | 10 | 120 | 3 | IPR002343 | |
| Domain | Spectrin_repeat | 3.40e-05 | 29 | 120 | 4 | IPR002017 | |
| Domain | SPEC | 5.07e-05 | 32 | 120 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.07e-05 | 32 | 120 | 4 | IPR018159 | |
| Domain | RRM_dom | 1.10e-04 | 227 | 120 | 8 | IPR000504 | |
| Domain | RRM | 1.20e-04 | 230 | 120 | 8 | PS50102 | |
| Domain | - | 1.81e-04 | 244 | 120 | 8 | 3.30.70.330 | |
| Domain | FN3 | 1.94e-04 | 185 | 120 | 7 | SM00060 | |
| Domain | Tyr_kinase_cat_dom | 2.58e-04 | 88 | 120 | 5 | IPR020635 | |
| Domain | TyrKc | 2.58e-04 | 88 | 120 | 5 | SM00219 | |
| Domain | Nucleotide-bd_a/b_plait | 2.64e-04 | 258 | 120 | 8 | IPR012677 | |
| Domain | FN3 | 3.02e-04 | 199 | 120 | 7 | PS50853 | |
| Domain | PROTEIN_KINASE_TYR | 4.05e-04 | 97 | 120 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 4.05e-04 | 97 | 120 | 5 | IPR008266 | |
| Domain | FN3_dom | 4.06e-04 | 209 | 120 | 7 | IPR003961 | |
| Domain | ACTININ_2 | 4.17e-04 | 23 | 120 | 3 | PS00020 | |
| Domain | ACTININ_1 | 4.17e-04 | 23 | 120 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.17e-04 | 23 | 120 | 3 | IPR001589 | |
| Domain | RRM | 5.09e-04 | 217 | 120 | 7 | SM00360 | |
| Domain | - | 6.04e-04 | 6 | 120 | 2 | 3.90.1290.10 | |
| Domain | GAR | 6.04e-04 | 6 | 120 | 2 | PS51460 | |
| Domain | GAS2 | 6.04e-04 | 6 | 120 | 2 | PF02187 | |
| Domain | - | 6.04e-04 | 6 | 120 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 6.04e-04 | 6 | 120 | 2 | IPR003108 | |
| Domain | GAS2 | 6.04e-04 | 6 | 120 | 2 | SM00243 | |
| Domain | fn3 | 6.28e-04 | 162 | 120 | 6 | PF00041 | |
| Domain | Plectin | 8.42e-04 | 7 | 120 | 2 | PF00681 | |
| Domain | Plectin_repeat | 8.42e-04 | 7 | 120 | 2 | IPR001101 | |
| Domain | PLEC | 8.42e-04 | 7 | 120 | 2 | SM00250 | |
| Domain | EF_Hand_1_Ca_BS | 9.39e-04 | 175 | 120 | 6 | IPR018247 | |
| Domain | PH_dom-spectrin-type | 1.43e-03 | 9 | 120 | 2 | IPR001605 | |
| Domain | Pkinase_Tyr | 1.47e-03 | 129 | 120 | 5 | PF07714 | |
| Domain | Bromodomain | 1.85e-03 | 38 | 120 | 3 | PF00439 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.98e-03 | 138 | 120 | 5 | IPR001245 | |
| Domain | EF_HAND_1 | 2.05e-03 | 204 | 120 | 6 | PS00018 | |
| Domain | EF-hand_7 | 2.20e-03 | 85 | 120 | 4 | PF13499 | |
| Domain | RRM_1 | 2.26e-03 | 208 | 120 | 6 | PF00076 | |
| Domain | BROMODOMAIN_2 | 2.31e-03 | 41 | 120 | 3 | PS50014 | |
| Domain | Bromodomain | 2.47e-03 | 42 | 120 | 3 | IPR001487 | |
| Domain | BROMO | 2.47e-03 | 42 | 120 | 3 | SM00297 | |
| Domain | - | 2.47e-03 | 42 | 120 | 3 | 1.20.920.10 | |
| Domain | Keratin_I | 2.83e-03 | 44 | 120 | 3 | IPR002957 | |
| Domain | - | 3.54e-03 | 14 | 120 | 2 | 3.90.890.10 | |
| Domain | PH | 3.64e-03 | 229 | 120 | 6 | PF00169 | |
| Domain | EF_HAND_2 | 3.80e-03 | 231 | 120 | 6 | PS50222 | |
| Domain | EF_hand_dom | 3.88e-03 | 232 | 120 | 6 | IPR002048 | |
| Domain | SH2 | 4.10e-03 | 101 | 120 | 4 | PF00017 | |
| Domain | SIAH-type | 4.63e-03 | 16 | 120 | 2 | IPR013323 | |
| Domain | SH2 | 5.54e-03 | 110 | 120 | 4 | SM00252 | |
| Domain | SH2 | 5.72e-03 | 111 | 120 | 4 | PS50001 | |
| Domain | Lig_chan-Glu_bd | 5.86e-03 | 18 | 120 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 5.86e-03 | 18 | 120 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.86e-03 | 18 | 120 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 5.86e-03 | 18 | 120 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 5.86e-03 | 18 | 120 | 2 | IPR001508 | |
| Domain | Lig_chan | 5.86e-03 | 18 | 120 | 2 | PF00060 | |
| Domain | PBPe | 5.86e-03 | 18 | 120 | 2 | SM00079 | |
| Domain | SH2 | 5.91e-03 | 112 | 120 | 4 | IPR000980 | |
| Domain | - | 5.91e-03 | 112 | 120 | 4 | 3.30.505.10 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 9.67e-06 | 42 | 97 | 5 | M27308 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 1.08e-05 | 7 | 97 | 3 | M27912 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP15 NCKAP1 RASGRF2 KALRN SPTBN1 SRC WHAMM ARMCX3 ARFGAP2 TAOK3 DST ARHGAP25 PHIP | 1.22e-05 | 450 | 97 | 13 | M27078 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | SOX10 RELN KALRN SPTBN1 TRPC5 SRC NFASC GRIN1 GRIN2B SHTN1 SCN10A ROBO3 FYN EPHA5 | 3.71e-05 | 575 | 97 | 14 | M29853 |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.02e-05 | 92 | 97 | 6 | M27201 | |
| Pathway | PID_EPHA_FWDPATHWAY | 8.34e-05 | 34 | 97 | 4 | M177 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.17e-04 | 37 | 97 | 4 | MM15022 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP15 NCKAP1 RASGRF2 KALRN SPTBN1 WHAMM ARMCX3 TAOK3 DST ARHGAP25 PHIP | 2.11e-04 | 439 | 97 | 11 | MM15595 |
| Pathway | BIOCARTA_PDZS_PATHWAY | 2.39e-04 | 18 | 97 | 3 | M22001 | |
| Pathway | WP_MRNA_PROCESSING | DCAF1 HNRNPDL RBM12B PAPOLB IGF2BP1 SYNJ2 ELAVL2 ELAVL1 ELAVL3 SNRPD3 BRWD1 | 2.66e-04 | 451 | 97 | 11 | MM15946 |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 3.31e-04 | 20 | 97 | 3 | M17670 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.84e-04 | 21 | 97 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.84e-04 | 21 | 97 | 3 | MM14996 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP15 NCKAP1 RASGRF2 KALRN SPTBN1 SRC WHAMM ARMCX3 ARFGAP2 TAOK3 DST ARHGAP25 ROPN1 PHIP | 3.94e-04 | 720 | 97 | 14 | M41838 |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 4.62e-04 | 5 | 97 | 2 | M27759 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 4.62e-04 | 5 | 97 | 2 | M47667 | |
| Pathway | REACTOME_REELIN_SIGNALLING_PATHWAY | 4.62e-04 | 5 | 97 | 2 | MM15504 | |
| Pathway | WP_NRF2ARE_REGULATION | 5.06e-04 | 23 | 97 | 3 | M39761 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 5.06e-04 | 23 | 97 | 3 | M27949 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 6.51e-04 | 25 | 97 | 3 | M27864 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 6.90e-04 | 6 | 97 | 2 | M47668 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 6.96e-04 | 155 | 97 | 6 | M522 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 7.32e-04 | 26 | 97 | 3 | M27053 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 8.19e-04 | 27 | 97 | 3 | M33 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 9.13e-04 | 28 | 97 | 3 | M837 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 9.13e-04 | 28 | 97 | 3 | MM14711 | |
| Pathway | PID_REELIN_PATHWAY | 9.13e-04 | 28 | 97 | 3 | M69 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.62e-04 | 7 | 97 | 2 | MM1566 | |
| Pathway | BIOCARTA_REELIN_PATHWAY | 9.62e-04 | 7 | 97 | 2 | M22049 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.01e-03 | 29 | 97 | 3 | M27309 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.03e-03 | 65 | 97 | 4 | MM14911 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 1.12e-03 | 30 | 97 | 3 | M257 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 1.12e-03 | 30 | 97 | 3 | M76 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.23e-03 | 31 | 97 | 3 | M877 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.31e-03 | 175 | 97 | 6 | MM15599 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 1.36e-03 | 32 | 97 | 3 | M275 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.47e-03 | 121 | 97 | 5 | M872 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP15 NCKAP1 RASGRF2 KALRN SPTBN1 SRC WHAMM ARMCX3 TAOK3 DST ARHGAP25 PHIP | 1.62e-03 | 649 | 97 | 12 | MM15690 |
| Pathway | REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING | 1.63e-03 | 9 | 97 | 2 | MM15059 | |
| Pubmed | ILF2 NCKAP1 KALRN SPTBN1 SRC NFASC GRIN1 GRIN2B KEAP1 SHTN1 KIF3A CCDC88C DST SHANK2 KIAA1217 ELAVL2 ELAVL1 ELAVL3 MACF1 PIP4K2C CNOT1 TP53BP2 | 4.09e-12 | 963 | 124 | 22 | 28671696 | |
| Pubmed | NMDA-receptor proteins are upregulated in the hippocampus of postnatal heterozygous reeler mice. | 1.11e-11 | 7 | 124 | 5 | 16438943 | |
| Pubmed | MYT1L SOX10 RELN KALRN UBE4B SPTBN1 ZMYND8 ZNF189 WHAMM GRIN2B SHTN1 UBASH3A KIF3A ZBTB44 THOP1 P4HTM DST MACF1 DAAM2 ASTN2 BRWD1 | 5.60e-09 | 1285 | 124 | 21 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBE4B KAT6A SRC ZNF189 NFASC SHTN1 GRHL2 NCS1 ITPKB SH3BP4 RLF THOP1 SMPDL3B SHANK2 SYNJ2 GCC2 KIAA1217 MACF1 ASTN2 MMP16 CNOT1 STAG2 | 1.43e-08 | 1489 | 124 | 22 | 28611215 |
| Pubmed | 1.91e-08 | 9 | 124 | 4 | 15716419 | ||
| Pubmed | ILF2 HYOU1 NCKAP1 KALRN SPTBN1 NFASC GRIN1 GRIN2B KIF3A ITPKB KRT76 DST SHANK2 SGPL1 KIAA1217 ELAVL1 ELAVL3 MACF1 PIP4K2C CNOT1 TP53BP2 | 3.57e-08 | 1431 | 124 | 21 | 37142655 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 11483655 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 11024032 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | NCKAP1 KALRN UBE4B SPTBN1 SRC GRIN1 GRIN2B SHANK2 MACF1 TP53BP2 | 7.34e-08 | 281 | 124 | 10 | 28706196 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTBN1 SRC EIF3E KEAP1 PPP1R13L SHTN1 ARFGAP2 DST SHANK2 SYNJ2 KIAA1217 MACF1 TP53BP2 | 1.27e-07 | 565 | 124 | 13 | 25468996 |
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 1.50e-07 | 14 | 124 | 4 | 29568343 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 10848602 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 10458595 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 21808035 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 17394141 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 9004271 | ||
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 4.40e-07 | 5 | 124 | 3 | 17229826 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 32828017 | ||
| Pubmed | 5.72e-07 | 19 | 124 | 4 | 23616926 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL ILF2 HYOU1 RBM12B SRC IGF2BP1 DST SMPDL3B ELAVL1 MACF1 FYN SNRPD3 ANAPC7 CNOT1 STAG2 PHIP | 7.89e-07 | 1024 | 124 | 16 | 24711643 |
| Pubmed | A hierarchy of Hu RNA binding proteins in developing and adult neurons. | 8.78e-07 | 6 | 124 | 3 | 9096138 | |
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 8.78e-07 | 6 | 124 | 3 | 2404338 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NCKAP1 SRC EIF3E ZNF189 UBASH3A NCS1 AXIN2 BLK FRK TAOK3 GTF2H3 DST PIP4K2C FYN ANAPC7 | 9.27e-07 | 910 | 124 | 15 | 36736316 |
| Pubmed | HNRNPDL ILF2 SPTBN1 ZMYND8 EIF3E KEAP1 KIF3A AXIN2 IGF2BP1 GTF2H3 ELAVL1 SNRPD3 ANAPC7 CNOT1 | 1.25e-06 | 809 | 124 | 14 | 32129710 | |
| Pubmed | Stabilization of Dll1 mRNA by Elavl1/HuR in neuroepithelial cells undergoing mitosis. | 1.53e-06 | 7 | 124 | 3 | 21346194 | |
| Pubmed | Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. | 1.53e-06 | 7 | 124 | 3 | 12526739 | |
| Pubmed | Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin. | 1.53e-06 | 7 | 124 | 3 | 9670010 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT8 RELN ILF2 SETX KALRN RBM12B SPTBN1 ZMYND8 IGF2BP1 DST ELAVL2 ELAVL1 ELAVL3 MACF1 SNRPD3 CNOT1 | 1.61e-06 | 1082 | 124 | 16 | 38697112 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ILF2 KIF3A IGF2BP1 DST SGPL1 ELAVL1 MACF1 FYN SNRPD3 STAG2 PHIP | 1.84e-06 | 498 | 124 | 11 | 36634849 |
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 12526740 | ||
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 31143101 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT8 SETX NCKAP1 SPTBN1 SHTN1 ITPKB SH3BP4 CCDC88C ARFGAP2 DST SYNJ2 KIAA1217 MACF1 TP53BP2 | 2.57e-06 | 861 | 124 | 14 | 36931259 |
| Pubmed | 3.20e-06 | 332 | 124 | 9 | 37433992 | ||
| Pubmed | 3.52e-06 | 251 | 124 | 8 | 27507650 | ||
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 17526495 | ||
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 9892651 | ||
| Pubmed | 6.16e-06 | 360 | 124 | 9 | 33111431 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 HNRNPDL ILF2 SETX NCKAP1 UBE4B SPTBN1 EIF3E RLF DST SGPL1 ELAVL1 MACF1 PIP4K2C SNRPD3 PHIP TP53BP2 | 6.57e-06 | 1353 | 124 | 17 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | KRT8 ILF2 HYOU1 SPTBN1 EIF3E GBP3 NBAS THOP1 DST ELAVL1 MACF1 DAAM2 CNOT1 | 6.62e-06 | 807 | 124 | 13 | 30575818 |
| Pubmed | Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development. | 7.15e-06 | 11 | 124 | 3 | 20824214 | |
| Pubmed | Transcriptional mechanisms of EphA7 gene expression in the developing cerebral cortex. | 7.15e-06 | 11 | 124 | 3 | 21940705 | |
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 15634788 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYT1L SPTBN1 SRC ZMYND8 GRIN1 UBASH3A STARD5 SH3BP4 KRT76 SYNJ2 LACC1 NOM1 VPS13A DAAM2 ARHGAP25 FYN | 9.24e-06 | 1242 | 124 | 16 | 30973865 |
| Pubmed | SPTBN1 ZMYND8 EIF3E KEAP1 PPP1R13L RLF ZBTB44 DST NOM1 MACF1 TP53BP2 | 9.31e-06 | 591 | 124 | 11 | 15231748 | |
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 33833454 | ||
| Pubmed | 1.03e-05 | 80 | 124 | 5 | 35803934 | ||
| Pubmed | 1.23e-05 | 13 | 124 | 3 | 16162939 | ||
| Pubmed | 1.23e-05 | 83 | 124 | 5 | 11114734 | ||
| Pubmed | Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. | 1.26e-05 | 2 | 124 | 2 | 21597037 | |
| Pubmed | Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. | 1.26e-05 | 2 | 124 | 2 | 8681387 | |
| Pubmed | Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. | 1.26e-05 | 2 | 124 | 2 | 21753020 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10079173 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11002341 | ||
| Pubmed | Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. | 1.26e-05 | 2 | 124 | 2 | 9381182 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22354875 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17045972 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26252487 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15082191 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15841096 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19487695 | ||
| Pubmed | Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. | 1.26e-05 | 2 | 124 | 2 | 11175854 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30504838 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26819771 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33113163 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26041915 | ||
| Pubmed | Computationally Discovered Potentiating Role of Glycans on NMDA Receptors. | 1.26e-05 | 2 | 124 | 2 | 28378791 | |
| Pubmed | Fyn stimulates the progression of pancreatic cancer via Fyn-GluN2b-AKT axis. | 1.26e-05 | 2 | 124 | 2 | 31957823 | |
| Pubmed | Redox regulation of neuronal migration in a Down Syndrome model. | 1.26e-05 | 2 | 124 | 2 | 12957649 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22711533 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25450957 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9763509 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 14573320 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21880917 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19224577 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20107840 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28283559 | ||
| Pubmed | c-Src but not Fyn promotes proper spindle orientation in early prometaphase. | 1.26e-05 | 2 | 124 | 2 | 22689581 | |
| Pubmed | Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. | 1.26e-05 | 2 | 124 | 2 | 20927585 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18068304 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19095845 | ||
| Pubmed | Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. | 1.26e-05 | 2 | 124 | 2 | 23840674 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15328026 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19784770 | ||
| Pubmed | Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. | 1.26e-05 | 2 | 124 | 2 | 15486073 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27040756 | ||
| Pubmed | Overlapping cortical malformations in patients with pathogenic variants in GRIN1 and GRIN2B. | 1.26e-05 | 2 | 124 | 2 | 35393335 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34647573 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23528480 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16289038 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19304657 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20438806 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34111520 | ||
| Pubmed | Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis. | 1.26e-05 | 2 | 124 | 2 | 25431428 | |
| Pubmed | Ion permeation properties of the cloned mouse epsilon 2/zeta 1 NMDA receptor channel. | 1.26e-05 | 2 | 124 | 2 | 7531804 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19446010 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28228639 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.27e-05 | 394 | 124 | 9 | 27248496 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HNRNPDL KRT8 ILF2 HYOU1 NCKAP1 SPTBN1 EIF3E SHTN1 IGF2BP1 DST ELAVL1 MACF1 SNRPD3 ANAPC7 CNOT1 | 1.54e-05 | 1149 | 124 | 15 | 35446349 |
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 21795692 | ||
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 24553115 | ||
| Interaction | CDH1 interactions | KRT8 ILF2 SPTBN1 SRC EIF3E KEAP1 PPP1R13L SHTN1 ARFGAP2 DST SHANK2 SYNJ2 SGPL1 KIAA1217 MACF1 FYN CCDC65 CDH3 ANAPC7 TP53BP2 | 1.98e-08 | 768 | 118 | 20 | int:CDH1 |
| Interaction | AGAP2 interactions | NCKAP1 KALRN UBE4B SPTBN1 SRC GRIN1 GRIN2B SHANK2 MACF1 TP53BP2 | 4.46e-07 | 210 | 118 | 10 | int:AGAP2 |
| Interaction | HOMER1 interactions | 1.71e-06 | 140 | 118 | 8 | int:HOMER1 | |
| Interaction | SHANK3 interactions | HYOU1 NCKAP1 KALRN SPTBN1 SRC NFASC GRIN1 GRIN2B PPP1R13L SHANK2 ELAVL1 MACF1 PIP4K2C | 6.88e-06 | 496 | 118 | 13 | int:SHANK3 |
| Interaction | EED interactions | DCAF1 HNRNPDL KRT8 ILF2 SETX HYOU1 NCKAP1 UBE4B RBM12B SPTBN1 EIF3E SH3BP4 ARFGAP2 IGF2BP1 THOP1 SGPL1 NOM1 ELAVL1 MACF1 PIP4K2C SNRPD3 CNOT1 STAG2 | 9.40e-06 | 1445 | 118 | 23 | int:EED |
| Interaction | RAC1 interactions | ARHGAP15 NCKAP1 RASGRF2 KALRN SPTBN1 SRC SLC38A5 GRIN1 GRIN2B SH3BP4 EHD2 TAOK3 DST SYNJ2 LACC1 VPS13A MACF1 FYN EPHA5 | 1.29e-05 | 1063 | 118 | 19 | int:RAC1 |
| Interaction | C2orf68 interactions | 2.37e-05 | 29 | 118 | 4 | int:C2orf68 | |
| Interaction | NEUROG3 interactions | 2.79e-05 | 149 | 118 | 7 | int:NEUROG3 | |
| Interaction | EPB41L3 interactions | 3.23e-05 | 272 | 118 | 9 | int:EPB41L3 | |
| Interaction | FBXL22 interactions | 5.36e-05 | 13 | 118 | 3 | int:FBXL22 | |
| Interaction | NRIP1 interactions | 6.45e-05 | 170 | 118 | 7 | int:NRIP1 | |
| Interaction | DLG4 interactions | NCKAP1 KALRN SPTBN1 SRC GRIN1 GRIN2B KIF3A SHANK2 ELAVL1 MACF1 FYN | 6.69e-05 | 449 | 118 | 11 | int:DLG4 |
| Interaction | RAC3 interactions | NCKAP1 SPTBN1 SLC38A5 SHTN1 ARMCX3 SH3BP4 EHD2 TAOK3 SYNJ2 KIAA1217 VPS13A MACF1 EPHA5 | 6.93e-05 | 619 | 118 | 13 | int:RAC3 |
| Interaction | PRKCE interactions | 7.21e-05 | 173 | 118 | 7 | int:PRKCE | |
| Interaction | FMR1 interactions | ILF2 NCKAP1 SPTBN1 KAT6A ZMYND8 IGF2BP1 KIAA1217 ELAVL2 ELAVL1 ELAVL3 MACF1 CNOT1 | 7.32e-05 | 536 | 118 | 12 | int:FMR1 |
| Interaction | GRB2 interactions | DCAF1 KRT8 HYOU1 NCKAP1 SPTBN1 SRC KIF3A IGF2BP1 SYNJ2 ELAVL1 VPS28 FYN CNOT1 TP53BP2 EPHA5 | 7.35e-05 | 806 | 118 | 15 | int:GRB2 |
| Interaction | BCL11B interactions | 7.38e-05 | 74 | 118 | 5 | int:BCL11B | |
| Interaction | SNCA interactions | ARHGAP15 SPTBN1 SRC GRIN2B KIF3A IGF2BP1 DST SGPL1 ELAVL1 MACF1 FYN SNRPD3 STAG2 PHIP | 7.73e-05 | 716 | 118 | 14 | int:SNCA |
| Interaction | CTNNB1 interactions | SOX10 SRC EIF3E GRIN1 GRIN2B KIF3A AXIN2 CCDC88C IGF2BP1 DST ABCA5 KIAA1217 ELAVL1 FYN CDH3 TP53BP2 EPHA5 | 8.05e-05 | 1009 | 118 | 17 | int:CTNNB1 |
| Interaction | TNIK interactions | NCKAP1 KALRN SPTBN1 GRIN1 GRIN2B DST SHANK2 KIAA1217 MACF1 EPHA5 | 8.25e-05 | 381 | 118 | 10 | int:TNIK |
| Interaction | YWHAB interactions | KRT8 NCKAP1 SPTBN1 KAT6A SRC SHTN1 NCS1 ITPKB SH3BP4 CCDC88C DST SYNJ2 GCC2 ELAVL1 MACF1 PIP4K2C TP53BP2 | 8.55e-05 | 1014 | 118 | 17 | int:YWHAB |
| Interaction | PCNT interactions | 8.79e-05 | 241 | 118 | 8 | int:PCNT | |
| Interaction | MEX3A interactions | SPTBN1 KAT6A ZMYND8 IGF2BP1 DST MACF1 ZNF518B CNOT1 TP53BP2 PLD4 | 8.80e-05 | 384 | 118 | 10 | int:MEX3A |
| Interaction | LNX1 interactions | KALRN RBM12B SRC ZBTB8B GRIN1 SHTN1 UBASH3A RBM20 AXIN2 ROBO3 ROPN1 PDZRN3 PDZRN4 | 8.81e-05 | 634 | 118 | 13 | int:LNX1 |
| Interaction | TTC3 interactions | 9.03e-05 | 124 | 118 | 6 | int:TTC3 | |
| Interaction | DLGAP1 interactions | 9.24e-05 | 180 | 118 | 7 | int:DLGAP1 | |
| Interaction | APPL1 interactions | 9.90e-05 | 182 | 118 | 7 | int:APPL1 | |
| Interaction | C2CD4B interactions | 1.27e-04 | 44 | 118 | 4 | int:C2CD4B | |
| Interaction | KCTD13 interactions | ILF2 HYOU1 NCKAP1 KALRN SPTBN1 NFASC GRIN1 GRIN2B KIF3A ITPKB DST SHANK2 SGPL1 KIAA1217 ELAVL1 ELAVL3 MACF1 PIP4K2C CNOT1 TP53BP2 | 1.64e-04 | 1394 | 118 | 20 | int:KCTD13 |
| Interaction | FRK interactions | 2.09e-04 | 50 | 118 | 4 | int:FRK | |
| Interaction | DAZL interactions | 2.13e-04 | 145 | 118 | 6 | int:DAZL | |
| Interaction | DCUN1D1 interactions | 2.18e-04 | 275 | 118 | 8 | int:DCUN1D1 | |
| Interaction | MAPRE1 interactions | KRT8 SPTBN1 SRC PPP1R13L DST SYNJ2 GCC2 KIAA1217 MACF1 FYN CNOT1 | 2.19e-04 | 514 | 118 | 11 | int:MAPRE1 |
| Interaction | RBM45 interactions | 2.19e-04 | 207 | 118 | 7 | int:RBM45 | |
| Interaction | SKAP2 interactions | 2.26e-04 | 51 | 118 | 4 | int:SKAP2 | |
| Interaction | DSCR9 interactions | 2.29e-04 | 147 | 118 | 6 | int:DSCR9 | |
| Interaction | KALRN interactions | 2.53e-04 | 96 | 118 | 5 | int:KALRN | |
| Cytoband | 20q12-q13 | 7.24e-06 | 2 | 124 | 2 | 20q12-q13 | |
| GeneFamily | Fibronectin type III domain containing | 1.87e-05 | 160 | 93 | 7 | 555 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 1.02e-04 | 18 | 93 | 3 | 498 | |
| GeneFamily | RNA binding motif containing | 1.15e-04 | 213 | 93 | 7 | 725 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 5.41e-04 | 7 | 93 | 2 | 1201 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.18e-04 | 8 | 93 | 2 | 939 | |
| GeneFamily | SH2 domain containing | 1.83e-03 | 101 | 93 | 4 | 741 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 5.06e-03 | 134 | 93 | 4 | 861 | |
| GeneFamily | EF-hand domain containing | 5.46e-03 | 219 | 93 | 5 | 863 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HNRNPDL SETX NCKAP1 PARG KAT6A ZMYND8 RLF NBAS TAOK3 DST SYNJ2 GCC2 VPS13A MACF1 FYN STAG2 PHIP TP53BP2 | 1.05e-07 | 856 | 123 | 18 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | MYT1L RELN KALRN FAT3 NFASC SHTN1 NCS1 KIF3A TAOK3 SHANK2 ELAVL2 ELAVL3 CDH3 EPHA5 PDZRN4 | 1.06e-07 | 584 | 123 | 15 | M39068 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN IKZF2 KALRN GPR37 SPTBN1 ZMYND8 NFASC KIF3A SH3BP4 EHD2 DST SGPL1 ELAVL1 ELAVL3 PIP4K2C FYN SNRPD3 PDZRN4 | 3.96e-06 | 1102 | 123 | 18 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | RELN IKZF2 KALRN GPR37 SPTBN1 ZMYND8 NFASC KIF3A SH3BP4 EHD2 DST SGPL1 ELAVL1 ELAVL3 PIP4K2C FYN SNRPD3 PDZRN4 | 5.20e-06 | 1124 | 123 | 18 | MM1070 |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | MYT1L FAT3 SPTBN1 NFASC GRIN1 NCS1 KIF3A SHANK2 ELAVL3 FYN EPHA5 | 1.97e-05 | 488 | 123 | 11 | M39104 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN | 4.42e-05 | 199 | 123 | 7 | M4194 | |
| Coexpression | GSE3982_MAST_CELL_VS_DC_UP | 4.42e-05 | 199 | 123 | 7 | M5426 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | KRT8 IKZF2 SETX KALRN FAT3 RBM20 RLF ZBTB44 IGF2BP1 DST PROKR2 ABCA5 VPS13A ELAVL2 ZNF518B MMP16 PHIP EPHA5 | 5.59e-07 | 806 | 119 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.40e-05 | 93 | 119 | 6 | gudmap_developingGonad_e16.5_ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_500 | 2.37e-05 | 102 | 119 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k3 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4 | 2.45e-05 | 210 | 119 | 8 | GSM403995_500 | |
| CoexpressionAtlas | CD positive, CD4 Control, 4+8-B220-, Spleen, avg-2 | 3.89e-05 | 224 | 119 | 8 | GSM403994_500 | |
| CoexpressionAtlas | cerebral cortex | MYT1L SOX10 RASGRF2 KALRN GPR37 FAT3 TRPC5 NFASC GRIN1 GRIN2B SHTN1 PTPRT TMEM121 NCS1 KIF3A SHANK2 PROKR2 ELAVL2 ELAVL3 MMP16 EPHA5 | 4.16e-05 | 1428 | 119 | 21 | cerebral cortex |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.39e-05 | 167 | 119 | 7 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | KRT8 IKZF2 SETX KALRN FAT3 SLC38A5 SHTN1 IGF2BP1 PROKR2 ELAVL2 ELAVL3 ZNF518B MMP16 PHIP EPHA5 | 5.34e-05 | 818 | 119 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_500 | 5.39e-05 | 118 | 119 | 6 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.27e-05 | 188 | 119 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k1 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 9.58e-05 | 189 | 119 | 7 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_500 | 1.19e-04 | 136 | 119 | 6 | gudmap_kidney_e10.5_UretericTip_HoxB7_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | SOX10 KRT8 HYOU1 GPR37 SRC SLC38A5 SHTN1 ITPKB DST SYNJ2 GCC2 KIAA1217 FYN CDH3 CNOT1 | 1.27e-04 | 884 | 119 | 15 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SETX FAT3 SHTN1 RLF ZBTB44 IGF2BP1 PROKR2 ABCA5 ELAVL2 ELAVL3 ZNF518B MMP16 PHIP EPHA5 | 1.98e-04 | 818 | 119 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.37e-04 | 369 | 119 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.96e-04 | 227 | 119 | 7 | gudmap_kidney_e10.5_UretericTip_HoxB7_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_100 | 3.19e-04 | 24 | 119 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k3_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_200 | 3.49e-04 | 166 | 119 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.58e-04 | 108 | 119 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | RELN IKZF2 FAT3 SRC SHTN1 GRHL2 CCDC88C SMPDL3B GCC2 ELAVL2 ELAVL3 MACF1 ASTN2 PHIP PDZRN3 | 4.09e-04 | 986 | 119 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000 | KRT8 RELN SETX SPTBN1 ZMYND8 SHTN1 GRHL2 CCDC88C DST ELAVL2 ELAVL3 ZNF518B ROBO3 CDH3 CNOT1 | 4.45e-04 | 994 | 119 | 15 | Facebase_RNAseq_e8.5_Floor Plate_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | KRT8 IKZF2 SHTN1 GRHL2 SH3BP4 CCDC88C IGF2BP1 KIAA1217 ELAVL2 CDH3 | 4.48e-04 | 491 | 119 | 10 | Facebase_RNAseq_e9.5_Olfactory Placode_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | DCAF1 KRT8 NCKAP1 UBE4B ZNF189 GRHL2 NCS1 NOM1 KIAA1217 CDH3 | 4.48e-04 | 491 | 119 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 4.55e-04 | 27 | 119 | 3 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | KRT8 IKZF2 SHTN1 GRHL2 CCDC88C PLCH2 ELAVL2 ELAVL3 MACF1 CDH3 | 4.77e-04 | 495 | 119 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 4.77e-04 | 495 | 119 | 10 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 4.88e-04 | 65 | 119 | 4 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 5.06e-04 | 178 | 119 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_100 | 5.17e-04 | 66 | 119 | 4 | gudmap_kidney_e10.5_UretericTip_HoxB7_100 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_OlfPlac_2500_K2 | 5.29e-04 | 328 | 119 | 8 | facebase_RNAseq_e9.5_OlfPlac_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.50e-04 | 330 | 119 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | KRT8 IKZF2 SRC ZBTB8B SHTN1 GRHL2 FRK DST PROKR2 PLCH2 PDZRN3 EPHA5 BRWD1 | 5.52e-04 | 800 | 119 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 5.85e-04 | 418 | 119 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | KRT8 IKZF2 SETX KALRN RBM12B FAT3 GRHL2 DST PROKR2 ABCA5 PLCH2 ZNF518B EPHA5 | 5.92e-04 | 806 | 119 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1 | 6.19e-04 | 336 | 119 | 8 | GSM538413_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 6.19e-04 | 336 | 119 | 8 | GSM605758_500 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | 6.44e-04 | 338 | 119 | 8 | GSM403987_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#2 | 6.74e-04 | 188 | 119 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K2 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | IKZF2 ARHGAP15 UBASH3A ITPKB CCDC88C PLCH2 ARHGAP25 CTLA4 FYN | 3.01e-09 | 188 | 124 | 9 | 71b7599e7e1d63cc0c8518c0501533755951d58f |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-09 | 193 | 124 | 9 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | IKZF2 ARHGAP15 UBASH3A ITPKB CCDC88C PLCH2 ARHGAP25 CTLA4 FYN | 3.96e-09 | 194 | 124 | 9 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.17e-09 | 200 | 124 | 9 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.17e-09 | 200 | 124 | 9 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.17e-09 | 200 | 124 | 9 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 7.43e-08 | 194 | 124 | 8 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 7.43e-08 | 194 | 124 | 8 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.73e-08 | 195 | 124 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.39e-08 | 200 | 124 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.39e-08 | 200 | 124 | 8 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.47e-07 | 167 | 124 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 4.85e-07 | 169 | 124 | 7 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.67e-07 | 173 | 124 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.41e-07 | 180 | 124 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.41e-07 | 180 | 124 | 7 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-07 | 182 | 124 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.98e-07 | 182 | 124 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-07 | 184 | 124 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-06 | 189 | 124 | 7 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-06 | 190 | 124 | 7 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.10e-06 | 191 | 124 | 7 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-06 | 192 | 124 | 7 | 69a2b04f03a1b82d067018379f7b8a116e954040 | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 1.18e-06 | 193 | 124 | 7 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 1.22e-06 | 194 | 124 | 7 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.31e-06 | 196 | 124 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 196 | 124 | 7 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.31e-06 | 196 | 124 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-06 | 197 | 124 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-06 | 198 | 124 | 7 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.40e-06 | 198 | 124 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-06 | 199 | 124 | 7 | 6150b272313d3fbf5ddcb3a8d51862d368220fe2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-06 | 199 | 124 | 7 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-06 | 199 | 124 | 7 | a255484ba77bd2741a541da278efc8cf4abbe570 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-06 | 199 | 124 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 199 | 124 | 7 | 6bce8e65859a35cfea1c210f9c9765952d492ed2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 200 | 124 | 7 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 200 | 124 | 7 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-06 | 200 | 124 | 7 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-06 | 200 | 124 | 7 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 142 | 124 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 142 | 124 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.61e-06 | 159 | 124 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.24e-06 | 162 | 124 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.69e-06 | 168 | 124 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.71e-06 | 97 | 124 | 5 | 442201932dc318846dc45f6c753e30b0d9a69f73 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.95e-06 | 100 | 124 | 5 | c50714a0819a40917d7a360623220576473f52ad | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 9.09e-06 | 173 | 124 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-05 | 176 | 124 | 6 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | 15-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.14e-05 | 180 | 124 | 6 | 99e2db9ad8e09fedc3542233553acece69f579f1 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 182 | 124 | 6 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-05 | 182 | 124 | 6 | dd1c59babf7211362452e3e264009d70004d99f6 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 182 | 124 | 6 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 1.25e-05 | 183 | 124 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 186 | 124 | 6 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 124 | 6 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 124 | 6 | 8eafd4bea692f7ef33de27dd53f9d1fe67deaad8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 124 | 6 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 124 | 6 | 924cc357b4c4ce8e9b05773bdab544f0b65474cc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 124 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.41e-05 | 187 | 124 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.41e-05 | 187 | 124 | 6 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-05 | 188 | 124 | 6 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.46e-05 | 188 | 124 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 1.55e-05 | 190 | 124 | 6 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.55e-05 | 190 | 124 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-05 | 191 | 124 | 6 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 191 | 124 | 6 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 191 | 124 | 6 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 191 | 124 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 191 | 124 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-05 | 191 | 124 | 6 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-05 | 192 | 124 | 6 | 92f141d5ac462f652f405efa73ac6ef751f40ea3 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.64e-05 | 192 | 124 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 193 | 124 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 193 | 124 | 6 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-05 | 193 | 124 | 6 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.69e-05 | 193 | 124 | 6 | 498d3a83bce6deff69aea71b18a43688e0a8ed7d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.69e-05 | 193 | 124 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 193 | 124 | 6 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 1.04e-07 | 194 | 123 | 10 | 3812_UP | |
| Drug | Sulfinpyrazone [57-96-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.26e-07 | 198 | 123 | 10 | 6230_UP | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 7.54e-07 | 185 | 123 | 9 | 4365_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.16e-05 | 196 | 123 | 8 | 2225_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.20e-05 | 197 | 123 | 8 | 5811_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.29e-05 | 199 | 123 | 8 | 5509_UP | |
| Disease | Bipolar Disorder | RELN GRIN1 GRIN2B NCS1 SHANK2 PROKR2 EGR3 ASTN2 CTLA4 PIP4K2C FYN | 3.27e-06 | 477 | 117 | 11 | C0005586 |
| Disease | colorectal cancer (implicated_via_orthology) | 5.94e-06 | 30 | 117 | 4 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 7.75e-06 | 32 | 117 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | silicosis (is_marker_for) | 4.66e-05 | 3 | 117 | 2 | DOID:10325 (is_marker_for) | |
| Disease | Schizophrenia | MYT1L SOX10 RELN NFASC GRIN2B NCS1 EGR3 ELAVL2 DAAM2 ASTN2 CTLA4 PIP4K2C FYN | 4.98e-05 | 883 | 117 | 13 | C0036341 |
| Disease | Intellectual Disability | 7.56e-05 | 447 | 117 | 9 | C3714756 | |
| Disease | cancer (implicated_via_orthology) | 9.99e-05 | 268 | 117 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | axial length measurement, refractive error | 2.31e-04 | 6 | 117 | 2 | EFO_0005318, MONDO_0004892 | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 2.52e-04 | 31 | 117 | 3 | C0023493 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 4.30e-04 | 8 | 117 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 4.30e-04 | 8 | 117 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | holoprosencephaly (is_implicated_in) | 4.30e-04 | 8 | 117 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | sick sinus syndrome | 4.30e-04 | 8 | 117 | 2 | MONDO_0001823 | |
| Disease | response to selective serotonin reuptake inhibitor, body mass index | 4.30e-04 | 8 | 117 | 2 | EFO_0004340, EFO_0005658 | |
| Disease | familial sick sinus syndrome | 4.30e-04 | 8 | 117 | 2 | MONDO_0012061 | |
| Disease | Colorectal Carcinoma | RASGRF2 KALRN SRC ZBTB8B PTPRT AXIN2 ABCA5 VPS13A PHIP PDZRN4 | 4.95e-04 | 702 | 117 | 10 | C0009402 |
| Disease | Neurodevelopmental Disorders | 5.22e-04 | 93 | 117 | 4 | C1535926 | |
| Disease | kidney disease (implicated_via_orthology) | 5.80e-04 | 41 | 117 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 5.96e-04 | 170 | 117 | 5 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | subiculum volume | 6.68e-04 | 43 | 117 | 3 | EFO_0009399 | |
| Disease | alkaline phosphatase measurement | ARHGAP15 SPTBN1 ITPKB BLK FRK IGF2BP1 SYNJ2 GCC2 MACF1 ARHGAP25 CNOT1 PDZRN4 | 7.18e-04 | 1015 | 117 | 12 | EFO_0004533 |
| Disease | vascular dementia (is_marker_for) | 8.38e-04 | 11 | 117 | 2 | DOID:8725 (is_marker_for) | |
| Disease | risk-taking behaviour | 9.46e-04 | 764 | 117 | 10 | EFO_0008579 | |
| Disease | Genetic chronic primary adrenal insufficiency | 1.18e-03 | 13 | 117 | 2 | Orphanet_101960 | |
| Disease | colon carcinoma (is_marker_for) | 1.18e-03 | 13 | 117 | 2 | DOID:1520 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.18e-03 | 13 | 117 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Malignant neoplasm of stomach | 1.28e-03 | 300 | 117 | 6 | C0024623 | |
| Disease | alcohol consumption measurement | MYT1L RELN ARHGAP15 RASGRF2 SPTBN1 GRIN2B UBASH3A NBAS IGF2BP1 ELAVL2 ASTN2 SNRPD3 IMPG2 | 1.31e-03 | 1242 | 117 | 13 | EFO_0007878 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | IKZF2 ARHGAP15 RASGRF2 ANKUB1 NFASC SHTN1 TTC29 ELAVL2 PDZRN3 BRWD1 | 1.35e-03 | 801 | 117 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | microglial activation measurement | 1.68e-03 | 59 | 117 | 3 | EFO_0010940 | |
| Disease | Sjogren syndrome | 1.76e-03 | 60 | 117 | 3 | EFO_0000699 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.80e-03 | 16 | 117 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | alcohol use disorder (is_implicated_in) | 1.80e-03 | 16 | 117 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.94e-03 | 62 | 117 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | Global developmental delay | 1.97e-03 | 133 | 117 | 4 | C0557874 | |
| Disease | carcinoma (implicated_via_orthology) | 2.12e-03 | 64 | 117 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | total blood protein measurement | 2.13e-03 | 449 | 117 | 7 | EFO_0004536 | |
| Disease | biological sex | 2.28e-03 | 230 | 117 | 5 | PATO_0000047 | |
| Disease | facial height measurement | 2.50e-03 | 142 | 117 | 4 | EFO_0007856 | |
| Disease | event free survival time, urinary bladder cancer | 2.55e-03 | 19 | 117 | 2 | EFO_0000482, MONDO_0001187 | |
| Disease | inferior parietal cortex volume measurement | 2.55e-03 | 19 | 117 | 2 | EFO_0010307 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 2.83e-03 | 20 | 117 | 2 | DOID:3328 (is_marker_for) | |
| Disease | migraine disorder | 3.05e-03 | 357 | 117 | 6 | MONDO_0005277 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.20e-03 | 152 | 117 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | interleukin 18 measurement | 3.46e-03 | 76 | 117 | 3 | EFO_0004581 | |
| Disease | PR interval | 3.65e-03 | 495 | 117 | 7 | EFO_0004462 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 3.73e-03 | 23 | 117 | 2 | MONDO_0015335 | |
| Disease | Autistic Disorder | 3.91e-03 | 261 | 117 | 5 | C0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NIMVTMINDSDYVSV | 936 | Q8WWZ7 | |
| VTDIMDVVTMQDYVQ | 171 | Q96LI9 | |
| ERQMETTQNLVDSYM | 51 | Q6ZS02 | |
| LQDIFMAMEQNYIDS | 171 | Q8IXS2 | |
| ADMVETQQLMRVYGA | 221 | Q9NZN4 | |
| FMENGYSSMDAVAQV | 986 | P54756 | |
| TEIQSVMEENAYQMF | 176 | Q9Y2T1 | |
| VMEENAYQMFLTSDI | 181 | Q9Y2T1 | |
| TMTNYDEAAMAIASL | 331 | Q14576 | |
| AEESMVASMRLAYQE | 266 | Q8N6H7 | |
| MMDEQQASLDYLSNQ | 101 | Q86XS5 | |
| MTVTNEYQHMLANSI | 231 | Q9UH62 | |
| AAVFAMTYSDMQTAA | 1016 | Q13625 | |
| KEQQMAYNTLMEVSA | 1216 | O75129 | |
| TEEYEEAMSTMQVSQ | 176 | Q9NXG6 | |
| TGEAIVAMINYNEAM | 966 | Q8IXT5 | |
| MKSTNQAFLEMAYTE | 551 | Q5T481 | |
| QAFLEMAYTEAAQAM | 556 | Q5T481 | |
| SAVEYAQSQMSLVSM | 891 | Q9UPQ7 | |
| YGMASEVQLMNASTQ | 321 | Q6ZMN7 | |
| SSVTMEDMNEYSNIE | 116 | O14979 | |
| LYEMELSQMQSHASD | 321 | Q01546 | |
| TARSNMDNMFESYIN | 131 | P05787 | |
| SNSIREAMVMANNVY | 386 | Q9UJX3 | |
| DTVYRQAVNSKMFEM | 466 | Q9NRJ5 | |
| INSMAAMQSLYAFDE | 106 | Q86T65 | |
| QADDQDMMESLFYTV | 266 | A6NHG9 | |
| NDDFMNALVNAYVMT | 81 | Q9Y4B6 | |
| TRAEMQMNVINTYTG | 206 | Q8TD91 | |
| MLDIVDAIYQMVGNT | 121 | P62166 | |
| INNNYMDTDNLMFTD | 836 | Q2M2H8 | |
| ELQTMTYRAMVDSQQ | 1366 | Q03001 | |
| YSSFMQAPEQEMVQV | 396 | Q9NZI8 | |
| MRAQYEAMVETNHQD | 276 | O76014 | |
| DMVTYFMNLSQANAQ | 336 | Q92485 | |
| SQDNLTMYMDLVDGI | 31 | Q9P219 | |
| IESMMSSVQKDNFYQ | 106 | Q86W56 | |
| SMNAYVNINRIMSVA | 361 | O60229 | |
| VAMATVNAMIAEYGC | 311 | Q8IV20 | |
| LVYNSMGTINQQAMD | 126 | Q9H0R5 | |
| TMTNYEEAAMAIASL | 291 | Q15717 | |
| HTAEQDMMVSAFYTI | 271 | Q8NGX1 | |
| HTAEQDMMVSAFYTI | 271 | Q8NH03 | |
| AYVVNNADDMDRIMT | 186 | Q9Y496 | |
| YLQNVSMEAAGQVMS | 221 | Q9UKS7 | |
| MMDQAINNAITYLGA | 316 | Q9UKS7 | |
| DMLTMQQNVYTCLDS | 1101 | A2RRP1 | |
| DMKVAMNVYELSSAA | 951 | Q9Y2A7 | |
| AMQAAVQYQDTLQAM | 6111 | Q9UPN3 | |
| ETQSMQIGASYMIQF | 916 | P78509 | |
| DYNCSSVVMLNEMDT | 1266 | O14522 | |
| AVMGSAQEFIYASVM | 326 | Q96BZ4 | |
| LQSYTQADEDPQMSM | 1456 | Q92794 | |
| DLYFSNVMLQDMQTD | 196 | O94856 | |
| QVDMAAQVASGMAYL | 331 | P42685 | |
| INTTAQNIMFYDMGS | 221 | Q9Y4L1 | |
| TKYMLVISNVNMNDA | 291 | Q8N9C0 | |
| YSNEDTFILNMESMV | 601 | Q6ISB3 | |
| LSMNTVHEILQAAMY | 96 | Q96M94 | |
| VQMYYEMIENCSSTT | 366 | O15354 | |
| AYMATGVSQQTMDLL | 516 | O15354 | |
| DSVVHYNQMATENVM | 41 | Q06889 | |
| YNQMATENVMDIGLT | 46 | Q06889 | |
| NLVDMAAQVAAGMAY | 366 | P06241 | |
| SAQIAEGMAYIERMN | 341 | P51451 | |
| SYQLIIQATNMAGMA | 1736 | Q8TDW7 | |
| DAQQTTLMNMEIADY | 1151 | Q8IWJ2 | |
| VMTLEQQDMVCYTAQ | 301 | Q12905 | |
| SDTNMVDFAMDVYKN | 46 | P60228 | |
| ISDMAVNYENTMIAA | 231 | Q9NSI6 | |
| FVTMTNYDEAAMAIA | 321 | Q12926 | |
| MNGAVMYQIDSVVRA | 156 | Q14145 | |
| VTEVCAATYMMGNEL | 81 | P16410 | |
| KSIFNSAMQEMEVYV | 336 | Q9ULU4 | |
| TYLADVEQSMGLMNS | 746 | Q8WUF5 | |
| NNIYEVMVLAMDNGS | 511 | P22223 | |
| VSVDNEDSYMLVMRN | 191 | Q8TBX8 | |
| LVDMAAQIASGMAYV | 366 | P12931 | |
| MFSNMTNYEVKASEQ | 541 | Q9P0V3 | |
| EQMIYMDDGVSSFVQ | 236 | O15056 | |
| SCEAQMFTVDSQMSY | 246 | Q8WUX1 | |
| NDMSNLVASQIMNYA | 1051 | O14827 | |
| YALNSLVIMNSANEM | 6 | P27987 | |
| AENETGNMAIHMVYQ | 441 | Q53QZ3 | |
| YVALDFEQEMAMVAS | 881 | P0CG39 | |
| AAQAAQYMAMEKATA | 831 | Q5T5P2 | |
| NMYEEMETLASVLQS | 381 | Q7Z333 | |
| VSMLAVEEYEEMQVN | 206 | A0MZ66 | |
| AILAEQYEQSINEMM | 766 | Q9H2K8 | |
| QYEQSINEMMASQAL | 771 | Q9H2K8 | |
| VMNLQDLYMAVTTQE | 211 | Q9H9Q4 | |
| NMASISGQLEELYMA | 376 | Q5C9Z4 | |
| ANTMVALMNVYQEED | 211 | Q8TF30 | |
| MILEDFCTTAYNTMN | 981 | Q9BZV3 | |
| YGMAQTTVDRNMVAE | 526 | O95470 | |
| DMNSVYERQGIAVMT | 811 | Q9UPX8 | |
| EMVTQGQTDAQYMFL | 1126 | Q01082 | |
| YVFNAVTQDTMPVME | 86 | A6NFN9 | |
| LAQSMENGLNYMAVA | 1746 | A5YKK6 | |
| DVMMENYGNLVSLDV | 41 | O75820 | |
| MDATAGSAYTDMNVV | 1131 | Q96RL7 | |
| AETMQSALAAMQQFY | 66 | P51512 | |
| AEISDMAVNYENTMI | 226 | Q8WWQ0 | |
| MAVNYENTMIAAGSC | 231 | Q8WWQ0 | |
| MSSAYLEQQMENLVV | 1576 | Q13129 | |
| VVEMNTAADIFKQYM | 876 | Q8N3U4 | |
| DIMYAAVDSREVNMQ | 1371 | Q9Y5Y9 | |
| VGDQLMSQSRVDMYA | 346 | O75038 | |
| SASHVSRMLNYMEQE | 176 | Q9HAT0 | |
| QDSYVLMASSQAEME | 126 | P42331 | |
| MANGTLYIANVQEMD | 501 | Q96MS0 | |
| AALSYMAAVVNANMK | 656 | O95155 | |
| SMAVMDAYLVEQNQG | 21 | Q9BTD3 | |
| AAQMSEAVAEKMLQY | 6 | Q9NSY2 | |
| MSNMETFDVAELDQY | 286 | P56693 | |
| IIDVLAAASYMQMFS | 101 | Q8NCP5 | |
| YDNMAELFAVVKTMQ | 36 | Q9UK41 | |
| YVVECIAMSNSMINT | 316 | Q8NFJ6 | |
| EDNMNCQMSNITVTY | 36 | P62318 | |
| HQMMLTVNNYIESAD | 406 | Q8NA56 | |
| IAMMNNSYQLIADHA | 621 | Q9UL62 | |
| FMMLYVQLVQGSSNE | 11 | O43915 | |
| ADYVLEMNMAKTSQT | 276 | P52888 | |
| AAEDSALQYMNFMNV | 166 | Q13889 | |
| YMDRCTASMVQIVNT | 561 | P57075 | |
| SIHAMQMQLYTAETN | 261 | Q8NC26 | |
| QTLLYQGSEAEAAMM | 41 | Q9C0D4 | |
| IEVMSAASYLQMNDV | 96 | Q8NAP8 | |
| LSENMNDRNYADSMS | 276 | Q9UL68 | |
| EQQASVMLNIMEEYD | 151 | Q13224 | |
| DDAATVYRAAAMLNM | 226 | Q05586 |